US 8,733,054 · Application 13/953,941 · Granted May 27, 2014
US 8,733,054
Method for producing a functional layer of a building shell, and building shell and functional layer
Estimated expiration
March 25, 2030
3y 169d remaining
- Could not fetch continuity data for application PCTEP2010001867: Resource not found (404)
Earliest effective filing
Mar 25, 2010
+ 20 years
Mar 25, 2030
PTA +0d
Mar 25, 2030
No TD
—
Final
Mar 25, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- July 30, 2013
- Earliest effective filing
- March 25, 2010
- Issue date
- May 27, 2014
- PTA
- 0 days
- Base expiry (before PTA)
- March 25, 2030
March 25, 2010 + 20 years = March 25, 2030
- Divisional of application 13/260,764, filed Nov 21, 2011, issued as US 8,763,338
- National stage entry of application PCTEP2010001867, filed Mar 25, 2010
- National stage entry of application PCTEP2010001867, filed Mar 25, 2010
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/953,941 · US 8,733,054
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,733,054: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8733054Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.